Update on the Management of Gastroenteropancreatic Neuroendocrine Tumors With Emphasis on the Role of Imaging

被引：31

作者：

Kim, Kyung Won ^{[1
,2
,3
]}

Krajewski, Katherine M. ^{[1
]}

Nishino, Mizuki ^{[1
]}

Jagannathan, Jyothi P. ^{[1
]}

Shinagare, Atul B. ^{[1
]}

Tirumani, Sree Harsha ^{[1
]}

Ramaiya, Nikhil H. ^{[1
]}

机构：

[1] Dana Farber Canc Inst, Dept Radiol, Boston, MA 02115 USA

[2] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea

[3] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea

来源：

AMERICAN JOURNAL OF ROENTGENOLOGY | 2013年 / 201卷 / 04期

基金：

美国国家卫生研究院;

关键词：

gastroenteropancreatic neuroendocrine tumor; guidelines; molecular targeted therapy; CLINICAL-PRACTICE GUIDELINES; CARCINOID-TUMORS; SOMATOSTATIN; METASTASIS; NEOPLASMS; DIAGNOSIS; ERA;

D O I：

10.2214/AJR.12.10240

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

OBJECTIVE. The purposes of this article are to review the current management of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) based on the 2012 National Comprehensive Cancer Network guidelines and to describe the role of imaging in a multidisciplinary approach. CONCLUSION. The management of GEP-NETs has become complex, requiring a multidisciplinary approach. The World Health Organization classification of GEP-NETs has been revised; the U.S. Food and Drug Administration has approved molecular targeted agents (sunitinib, everolimus) for the treatment of pancreatic NETs; and the National Comprehensive Cancer Network clinical practice guidelines have been updated.

引用

页码：811 / 824

页数：14

共 50 条

[1] Update in the management of gastroenteropancreatic neuroendocrine tumors
Sedlack, Andrew J. H.
Varghese, Diana Grace
Naimian, Amirkia
Anari, Pouria Yazdian
Bodei, Lisa
Hallet, Julie
Riechelmann, Rachel P.
Halfdanarson, Thor
Capdevilla, Jaume
Del Rivero, Jaydira
[J]. CANCER, 2024, 130 (18) : 3090 - 3105
[2] Gastroenteropancreatic Neuroendocrine Tumors: Role of Imaging in Diagnosis and Management
Sahani, Dushyant V.
Bonaffini, Pietro A.
Fernandez-Del Castillo, Carlos
Blake, Michael A.
[J]. RADIOLOGY, 2013, 266 (01) : 38 - 61
[3] An update on the diagnosis and management of gastroenteropancreatic neuroendocrine tumors
Ito, Tetsuhide
[J]. ANNALS OF ONCOLOGY, 2018, 29 : 42 - 42
[4] An Update on Gastroenteropancreatic Neuroendocrine Tumors
Cives, Mauro
Strosberg, Jonathan
[J]. ONCOLOGY-NEW YORK, 2014, 28 (09): : 749 - 758
[5] Update on gastroenteropancreatic neuroendocrine tumors
Andreasi, Valentina
Partelli, Stefano
Muffatti, Francesca
Manzoni, Marco F.
Capurso, Gabriele
Falconi, Massimo
[J]. DIGESTIVE AND LIVER DISEASE, 2021, 53 (02) : 171 - 182
[6] Endoscopic imaging in the management of gastroenteropancreatic neuroendocrine tumors
Pellicano, Rinaldo
Fagoonee, Sharmila
Altruda, Fiorella
Bruno, Mauro
Saracco, Giorgio M.
De Angelis, Claudio
[J]. MINERVA ENDOCRINOLOGICA, 2016, 41 (04) : 490 - 498
[7] Gastroenteropancreatic Neuroendocrine Tumors: Update on Therapeutics
Ganetsky, Alex
Bhatt, Valkal
[J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (06) : 851 - 862
[8] Imaging of gastroenteropancreatic neuroendocrine tumors
Tan, Eik Hock
Tan, Cher Heng
[J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2011, 2 (01): : 28 - 43
[9] The management of neuroendocrine gastroenteropancreatic tumors
Berrad, S.
Erraichi, H.
Nouikh, L.
Messoudi, K.
Oualla, K.
Benbrahim, Z.
Arifi, S.
Mellas, N.
[J]. ANNALS OF ONCOLOGY, 2019, 30
[10] Update on the Role of Somatostatin Analogs for the Treatment of Patients With Gastroenteropancreatic Neuroendocrine Tumors
Toumpanakis, Christos
Caplin, Martyn E.
[J]. SEMINARS IN ONCOLOGY, 2013, 40 (01) : 56 - 68

← 1 2 3 4 5 →